New predictive markers for dasatinib responsiveness in triple-negative breast cancer: A biomarker discovery study

Ortega-Alvarez, D; Tebar, D; Casado, M; Castillo, E; Guardia, C; Olivares-Osuna, D; Musulén, E; Mereu, E; Luengo, G; Galán-Moya, EM; Rodilla, V